Centene Corporation (NYSE: CNC) today announced it is taking additional steps to further protect members and employees from COVID-19, to educate its key stakeholders about the benefits of the vaccine, and to prepare for anticipated vaccine.
Centene Corporation announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases.